GCNT2 and acute myeloid leukemia: Then the two independent AML cohorts (TCGA-LAML and TARGET-LAML) containing a total of 351 samples were combined and subjected to Kaplan‐Meier analysis, it was revealed that patients with high GCNT2 expression presented remarkably worse OS than those with low GCNT2 expression (P = 1.3e-3, HR = 1.58), (Figure 3B).